Last quarter (Q4 2023), Burning Rock Biotech's total revenue was $121.57M, an increase of Infinity% from the same quarter last year. In Q4, Burning Rock Biotech's net income was $-162.21M. See Burning Rock Biotech’s key income statements, including revenue, expenses, profit, and income.

Income Statement	TTM	Dec 23	Dec 22	Dec 21	Dec 20
Total Revenue	$ 249.13M	$ 537.92M	$ 563.24M	$ 507.86M	$ 429.90M
Cost of Revenue	$ 84.62M	$ 174.21M	$ 183.20M	$ -220.43M	$ -197.94M
Gross Profit	$ 164.52M	$ 363.71M	$ 380.04M	$ 728.29M	$ 627.84M
Operating Expense	$ 509.65M	$ 1.03B	$ 1.36B	$ 1.16B	$ 726.33M
Operating Income	$ -345.14M	$ -668.84M	$ -600.37M	$ -432.92M	$ -98.48M
Net Non Operating Interest Income Expense	$ 9.56M	$ 17.96M	$ 102.00K	$ -1.54M	$ -667.00K
Other Income Expense	-	-	$ -152.00K	$ -199.00K	$ -2.62M
Pretax Income	$ -335.67M	$ -651.30M	$ -969.25M	$ -431.65M	$ -93.31M
Tax Provision	$ 1.52M	$ 2.39M	$ 1.99M	$ 899.00K	$ -1.59M
Earnings From Equity Interest Net Of Tax	-	-	$ 294.00K	$ 483.00K	$ 275.00K
Net Income Common Stockholders	$ -337.19M	$ -653.69M	$ -591.19M	$ -432.55M	$ -158.00M
Basic EPS	$ -3.62	$ -6.38	-	-	-
Diluted EPS	$ -3.62	$ -6.38	-	-	-
Basic Average Shares	$ 170.07M	$ 85.07M	-	-	-
Diluted Average Shares	$ 170.07M	$ 85.07M	-	-	-
Dividend Per Share	-	-	-	-	-
Total Operating Income As Reported	-	-	-	-	-
Reported Normalized Basic E P S	-	-	-	-	-
Reported Normalized Diluted E P S	-	-	-	-	-
Rent Expense Supplemental	-	-	-	-	-
Total Expenses	$ 1.21B	$ 1.21B	$ 1.54B	$ 940.78M	$ 528.39M
Net Income From Continuing And Discontinued Operation	$ -337.19M	$ -653.69M	$ -971.23M	$ -432.55M	$ -93.31M
Normalized Income	$ -118.44M	$ -478.71M	-	-	-
Interest Expense	-	-	-	-	-
EBIT	$ -161.14M	$ -651.30M	$ -969.35M	$ -430.12M	$ -92.65M
EBITDA	$ -27.74M	$ -517.90M	$ -951.36M	$ -430.12M	$ -59.34M

Currency in USD

Burning Rock Biotech Earnings and Revenue History

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing